Patheon N.V. Ordinary shares, pPTHN
A contract development and manufacturing organization (CDMO) providing pharmaceutical development, drug substance manufacturing, and drug product formulation services to the biopharmaceutical industry. The company operates a global network of facilities and is a key partner for both emerging biotech firms and large pharmaceutical companies. Investors track Patheon for its exposure to the outsourced drug manufacturing market and its role in the pharmaceutical supply chain.
Congressional Interest in Patheon N.V. Ordinary shares, p (PTHN)
1 member of Congress has disclosed 1 trade in Patheon N.V. Ordinary shares, p (PTHN), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading PTHN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-10-27 | Diana Harshbarger | buy | $1K-$15K |